Related Experiment Video
Updated: Aug 5, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Control of a Candida glabrata prosthetic endovascular infection with posaconazole
G M Anstead1, M Martinez, J R Graybill
1Medical Service, Department of Veterans Affairs Medical Center, South Texas Veterans Heatlh Care System, San Antonio, USA.
Abstract:
A 63-year-old man with a history of cirrhosis of the liver developed Candida glabrata fungemia after undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. Treatment with oral fluconazole was initially effective, but when the patient became neutropenic, subsequent blood cultures grew C. glabrata and a thrombus developed, which partially occluded the stent. Despite treatment with fluconazole, blood cultures remained positive for C. glabrata. Treatment with posaconazole resulted in clinical improvement and the patient had only intermittently positive fungal cultures for 6 weeks. A CT scan showed resolution of the inferior vena cava thrombus. Subsequently, the patient developed hepatocellular carcinoma and hepatic encephalopathy and became noncompliant with posaconazole. Blood cultures again became positive for C. glabrata. The patient died a few weeks after the diagnosis of hepatocellular carcinoma, but the cause of death was believed to be worsening liver dysfunction, not C. glabrata infection. Posaconazole had controlled the infection for about 3 months prior to his death. In conclusion, posaconazole may be a useful option in the management of prosthetic endovascular infections caused by C. glabrata.
Insights
Posaconazole effectively managed Candida glabrata fungemia in a liver cirrhosis patient post-TIPS, demonstrating its potential for prosthetic endovascular infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Gastroenterology
Background:
- Transjugular intrahepatic portosystemic shunt (TIPS) placement is a procedure used in patients with liver cirrhosis.
- Candida glabrata fungemia is a serious bloodstream infection that can occur in immunocompromised patients.
- Prosthetic endovascular infections pose significant treatment challenges.
Observation:
- A patient with liver cirrhosis developed Candida glabrata fungemia after TIPS placement.
- Initial fluconazole treatment failed when the patient became neutropenic, with persistent fungemia and thrombus formation.
- Posaconazole treatment led to clinical improvement and partial resolution of the thrombus.
Findings:
- Posaconazole controlled Candida glabrata fungemia for approximately 3 months in a complex patient case.
- Resolution of inferior vena cava thrombus was observed on CT scan during posaconazole therapy.
- Despite initial control, infection recurred when the patient became noncompliant with posaconazole due to other health issues.
Implications:
- Posaconazole may be a valuable therapeutic option for prosthetic endovascular infections caused by Candida glabrata.
- This case highlights the challenges in managing fungal infections in patients with advanced liver disease and indwelling devices.
- Maintaining treatment compliance is crucial for successful outcomes in managing chronic or recurrent fungal infections.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

